Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelofusin Prolotherapy for Pressure Injuries
NCT05874284Phase 1Completed
- Sponsor
- Fenerbahçe University
- Start
- Jun 2023
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of succinylated gelatin in pressure ulcer (2 arms), sponsored by Fenerbahçe University. Primary endpoint: Wound healing time at 3 days. Started Jun 2023; status: completed.
02
Drugs
succinylated gelatin
03
Conditions
pressure ulcer
Beyond the preview
Go deeper on NCT05874284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05874284.